Gene Delivery Systems Market
Gene Delivery Systems Market By Delivery (Viral Gene Delivery, Non-viral Gene Delivery), By Route of Administration (Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal), By Application (Infectious Diseases, Oncology, CVD, Urology, CNS) & Region - Global Market Insights 2022 to 2027
Analysis of Gene Delivery Systems market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Gene Delivery Systems Market Outlook (2022 to 2027)
The global gene delivery systems market currently accounts for a valuation of US$ 3 billion and is expected to reach US$ 4.1 billion by the end of 2027. Global demand for gene delivery systems is predicted to magnify at a CAGR of 6.5% from 2022 to 2027.
Demand for viral gene delivery systems is anticipated to rise rapidly at a CAGR of 7% through 2027. Viral gene delivery systems are used for treating genetic illnesses caused by the insertion or deletion of a gene.
| Report Attributes | Details |
|---|---|
| Gene Delivery Systems Market Size (2022) | US$ 3 Billion |
| Projected Market Value (2027) | US$ 4.1 Billion |
| Global Market Growth Rate (2022 to 2027) | 6.5% CAGR |
| Market Share of Viral Gene Delivery | 85% |
| Share in Gene Therapy Market (2022) | 30% |
| Key Companies Profiled | Amgen, Inc.; Bayer AG; Pfizer, Inc.; Novartis AG; Johnson & Johnson; Human Stem Cells Institute; Oxford Biomedica plc; Shanghai Sunway Biotech Co., Ltd.; Sibiono GeneTech Co. Ltd. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Demand Analysis of Gene Delivery Systems (2017 to 2021) Vs Market Projections (2022 to 2027)
“Rising Prevalence of Chronic Diseases Driving Demand for Gene Delivery Systems”
According to Fact.MR, a market research and competitive intelligence provider, the gene delivery systems market is projected to increase at a CAGR of 6.5% from 2022 to 2027.
Gene delivery systems can significantly improve the human therapies used to cure disease. A process called gene delivery inserts foreign DNA into host cells. Growing adoption of targeted therapies and innovations in gene delivery systems are expected to drive market expansion over the coming years.
Market growth is primarily driven by the rising prevalence of chronic diseases and the growing demand for targeted medicines. Market expansion has been fueled by the expanding ongoing research and development in the field of genetics at a global level, increasing need for genetic disorder therapeutics, and rising demand for self-administration tools for home-based health care.
Other factors that are anticipated to contribute to market expansion include the rising demand for targeted and low-dose frequency drug delivery, the increasing need for advanced technologies for targeted systems, and the introduction of new and superior methods such as adenovirus vectors, lentivirus vectors, and retrovirus vectors.
All of these important variables are anticipated to fuel market expansion for gene delivery systems over the coming years.
What Aspects Drive Gene Delivery Systems Market Growth?
“Development of Cell & Gene Therapies Supporting Market Expansion”
The development of cell and gene therapies has significantly altered not just how genetic and incurable diseases are treated, but also how the entire pharmaceutical industry is structured. One of the main factors influencing the market for gene delivery methods is the rapidly changing landscape of innovative medicines.
The global market for gene delivery systems is expanding due to the increased prevalence of different chronic diseases such as cancer, diabetes, cardiovascular diseases, and other chronic diseases as well as technological advancements in drug administration.
The demand for gene delivery solutions has increased as a result of patients' and physicians' changing preferences. The development of the global market for gene delivery systems has been considerably aided by the advent of auto-injectors, genealogy products & services, biopharmaceutical classification techniques, implants with configurable shapes and sizes, and adaptive aerosol delivery systems.
The demand for gene delivery systems has increased due to the increasing use of gene treatments and novel drugs as a result of growing public awareness about the existence of new medications that can successfully treat chronic conditions. One of the key factors propelling the market is the increase in funding for the discovery of new pharmaceuticals and therapies for the treatment of incurable diseases.
“Introduction of Several Revolutionary Tools for Genetic Modifications”
The activation of physical gene delivery techniques such as megnetoporation, optoporation, sonoporation, and electroporation has been made possible by emerging nanotechnology and physical technology. More people are paying attention to this technological breakthrough because of its better functionality and nontoxicity. These factors have also increased the use of gene delivery systems.
Some of the main driving factors are technological advancements in viral vectors, an expanding pipeline of advanced therapies, and an increase in the number of regulatory approvals for innovative therapy products.
The development of new gene delivery techniques has been aided by the introduction of several revolutionary tools for genetic modifications that have made it easier for the scientific community to outline the complexities of disease at the genomic level.
The market revenue is also being boosted by continuous research to create clinically useful vectors, including adeno-associated virus vectors, sendai virus vectors, and herpes simplex virus vectors to treat chronic diseases such as cancer, Alzheimer's, and others with innovative medicines.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How is Market Expansion Being Restrained to Some Extent?
“High Treatment Costs and Efficacy & Safety Concerns”
The market is anticipated to be constrained by high treatment costs, efficacy and safety concerns, long clinical study procedures, stringent regulations for product approvals, and an increase in drug recalls.
How are Start-ups Sculpting Their Progress in the Gene Delivery Systems Market?
“Aspiring Market Players Focused on Innovations in Non-viral Gene Therapies”
It is projected that the growing public and private interest in gene delivery technologies would hasten the entry of new firms into the market. New companies are investing in R&D to create high-end gene delivery systems and address problems, worries, and adverse effects associated with their use.
Viral vectors are limited by the size of the virus chassis, which makes it difficult to transmit significant genetic payloads. Additionally, some people may develop cancer or experience inflammatory reactions as a result of viral gene therapy. These issues are resolved by non-viral gene therapies, which successfully expand the patient population who can benefit from gene therapy.
- Generation Bio, a start-up based in the U.S., provides non-viral gene treatment options. Their technology, which uses a unique closed-ended deoxyribonucleic acid (ceDNA) system, may deliver one or multiple genes to a cell. It also can provide long-lasting gene expression by allowing higher loads.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Which Region Spearheads Gene Delivery System Demand?
“Higher Consumer Awareness of Improved Drug Delivery Systems North America”
North America leads the gene delivery systems market. The market is expanding as a result of rising demand for biological gene delivery systems, rising adoption of innovative products, and rising consumer awareness of improved drug delivery systems.
Increased prevalence of chronic diseases, technological advancements in genetic analyzer systems, and the presence of key players are driving market growth in the region.
Increasing rates of hospitalizations, technological advancements in drug delivery systems, and rising research and innovation initiatives for the development of gene delivery systems are driving market expansion in the region.
Country-wise Insights
Why is the Market for Gene Delivery Systems Prominent in the U.S?
“Growing Public & Private Investments in Development of Advanced Gene Therapy Products”
According to research, approximately 60% of the U.S. population has at least one chronic illness. The U.S. market is growing as a result of rising viral gene delivery system usage, growing public and private investments in the development of advanced gene therapy products, and a well-established biotechnology industry.
The growing awareness among the population of advanced technology for the treatment of hereditary and rising involvement by key businesses in the production and marketing of gene delivery technologies are the factors driving market expansion.
Why are Suppliers of Gene Delivery Systems Attracted to China?
“Rapid Expansion of Pharmaceutical Industry in China”
The gene delivery systems market in China is expected to rise at a CAGR of 6% over the forecast period.
China is recognised as a gene therapy hub. Market expansion is attributed to the growing acceptance of personalized medications, the rapid expansion of the pharmaceutical industry, the presence of a large population, and the rising incidence of diseases brought on by pollution as a result of rapid industrialization and urbanization.
Due to a huge patient base and the increase of production capacity by major players to meet the rising demand for gene delivery systems, the market in China is anticipated to grow quickly.
Category-wise Insights
Why are Viral Gene Delivery Systems Mostly Preferred?
“Strong Emphasis by Governments on Public Education about Viral Gene Delivery Systems”
Based on the delivery, the gene delivery systems market is divided into viral gene delivery and non-viral gene delivery. Viral gene delivery systems account for 85% share of the global market.
Due to characteristics such as long-term expression, short-term expression, and therapeutic gene efficacy as well as recent technological advancements that have created numerous growth opportunities in the healthcare sector, it is anticipated that viral gene delivery systems will continue to hold a dominant market share. Market growth of gene delivery systems has also been aided by the rising prevalence of cardiovascular ailments.
These gene delivery technologies have gained widespread acceptance as a result of governments placing a greater emphasis on public education regarding these treatments.
Which Application Accounts for the Highest Sales of Gene Delivery Systems?
“Growing Prevalence of Cancer Driving High Demand for Gene Delivery Systems in Oncology”
The gene delivery systems market is segmented into infectious diseases, oncology, CVD, urology, CNS, and others based on the application. The global gene delivery systems market is dominated by the oncology segment in terms of revenue. Global demand for gene delivery devices is being driven by an increase in cancer incidence in all regions.
The demand for innovative drug delivery systems in the oncology segment has increased due to the rising incidence of malignancies such as leukemia, brain tumors, colon cancer, stomach cancer, and others.
Growing prevalence of cancer disorders, the increased emphasis on research to create a successful cancer treatment, and rising funding in cancer research are the key drivers of segment growth.
Competitive Landscape
Market expansion is being fueled by strategic agreements formed by companies developing cell and gene therapies with vector suppliers. Due to the presence of numerous domestic and international producers of gene delivery systems, the global market for gene delivery systems is very competitive.
For instance :
- Nanoparticles demonstrated their effectiveness as prospective carriers for clinical utilization due to their customizable shape and biological activities.
- Brammer Bio, a company that produces viral vectors for gene therapies, was acquired by Thermo Fisher Scientific.
Segments of Gene Delivery Systems Industry Research
-
By Delivery :
- Viral Gene Delivery
- Non-viral Gene Delivery
-
By Route of Administration :
- Oral
- Injectable
- Inhalation
- Transdermal
- Ocular
- Nasal
- Others
-
By Application :
- Infectious Diseases
- Oncology
- CVD
- Urology
- CNS
- Others
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Global Market Demand (US$ Mn) Analysis 2017 to 2021 and Forecast, 2022 to 2027
- 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, By Delivery
- 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Route of Administration
- 7.1. Oral
- 7.2. Injectable
- 7.3. Inhalation
- 7.4. Transdermal
- 7.5. Ocular
- 7.6. Nasal
- 7.7. Others
- 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Application
- 8.1. Infectious Diseases
- 8.2. Oncology
- 8.3. CVD
- 8.4. Urology
- 8.5. CNS
- 8.6. Others
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
- 10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 14. South Asia & Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. Amgen, Inc.
- 17.2. Bayer AG
- 17.3. Pfizer, Inc.
- 17.4. Novartis AG
- 17.5. Johnson & Johnson
- 17.6. Human Stem Cells Institute
- 17.7. Oxford Biomedica plc
- 17.8. Shanghai Sunway Biotech Co., Ltd.
- 17.9. Sibiono GeneTech Co. Ltd.
- 18. Assumptions And Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2017 to 2021
Table 02: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2022 to 2027
Table 03: Global Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Delivery, 2022 to 2027
Table 04: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2017 to 2021
Table 05: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2022 to 2027
Table 06: Global Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2022 to 2027
Table 07: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 08: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2022 to 2027
Table 09: Global Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027
Table 10: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Region, 2017 to 2021
Table 11: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Region, 2022 to 2027
Table 12: Global Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Region, 2022 to 2027
Table 13: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 14: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 15: North America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 16: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2017 to 2021
Table 17: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2022 to 2027
Table 18: North America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Delivery, 2022 to 2027
Table 19: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2017 to 2021
Table 20: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2022 to 2027
Table 21: North America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2022 to 2027
Table 22: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 23: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2022 to 2027
Table 24: North America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027
Table 25: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 26: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 27: Latin America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 28: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2017 to 2021
Table 29: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2022 to 2027
Table 30: Latin America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Delivery, 2022 to 2027
Table 31: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2017 to 2021
Table 32: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2022 to 2027
Table 33: Latin America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2022 to 2027
Table 34: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 35: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2022 to 2027
Table 36: Latin America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027
Table 37: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 38: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 39: Europe Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 40: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2017 to 2021
Table 41: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2022 to 2027
Table 42: Europe Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Delivery, 2022 to 2027
Table 43: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2017 to 2021
Table 44: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2022 to 2027
Table 45: Europe Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2022 to 2027
Table 46: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 47: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2022 to 2027
Table 48: Europe Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027
Table 49: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 50: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 51: East Asia Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 52: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2017 to 2021
Table 53: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2022 to 2027
Table 54: East Asia Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Delivery, 2022 to 2027
Table 55: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2017 to 2021
Table 56: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2022 to 2027
Table 57: East Asia Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2022 to 2027
Table 58: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 59: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2022 to 2027
Table 60: East Asia Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027
Table 61: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 62: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 63: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 64: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2017 to 2021
Table 65: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2022 to 2027
Table 66: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Delivery, 2022 to 2027
Table 67: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2017 to 2021
Table 68: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2022 to 2027
Table 69: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2022 to 2027
Table 70: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 71: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2022 to 2027
Table 72: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027
Table 73: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 74: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 75: MEA Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 76: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2017 to 2021
Table 77: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2022 to 2027
Table 78: MEA Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Delivery, 2022 to 2027
Table 79: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2017 to 2021
Table 80: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2022 to 2027
Table 81: MEA Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2022 to 2027
Table 82: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 83: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2022 to 2027
Table 84: MEA Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 04: Global Market Incremental $ Opportunity, 2022 to 2027
Figure 05: Global Market Share and BPS Analysis by Delivery, 2022 & 2027
Figure 06: Global Market Y-o-Y Growth Projections by Delivery, 2022 to 2027
Figure 07: Global Market Attractiveness Analysis by Delivery, 2022 to 2027
Figure 08: Global Market Share and BPS Analysis by Route of Administration, 2022 & 2027
Figure 09: Global Market Y-o-Y Growth Projections by Route of Administration, 2022 to 2027
Figure 10: Global Market Attractiveness Analysis by Route of Administration, 2022 to 2027
Figure 11: Global Market Share and BPS Analysis by Application, 2022 & 2027
Figure 12: Global Market Y-o-Y Growth Projections by Application, 2022 to 2027
Figure 13: Global Market Attractiveness Analysis by Application, 2022 to 2027
Figure 14: Global Market Share and BPS Analysis by Region, 2022 & 2027
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2022 to 2027
Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2027
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2022 to 2027
Figure 20: North America Market Incremental $ Opportunity, 2022 to 2027
Figure 21: North America Market Share Analysis by Country, 2022 & 2027
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 23: North America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 24: North America Market Share and BPS Analysis by Delivery, 2022 & 2027
Figure 25: North America Market Y-o-Y Growth Projections by Delivery, 2022 to 2027
Figure 26: North America Market Attractiveness Analysis by Delivery, 2022 to 2027
Figure 27: North America Market Share and BPS Analysis by Route of Administration, 2022 & 2027
Figure 28: North America Market Y-o-Y Growth Projections by Route of Administration, 2022 to 2027
Figure 29: North America Market Attractiveness Analysis by Route of Administration, 2022 to 2027
Figure 30: North America Market Share and BPS Analysis by Application, 2022 & 2027
Figure 31: North America Market Y-o-Y Growth Projections by Application, 2022 to 2027
Figure 32: North America Market Attractiveness Analysis by Application, 2022 to 2027
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 36: Latin America Market Incremental $ Opportunity, 2022 to 2027
Figure 37: Latin America Market Share Analysis by Country, 2022 & 2027
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 39: Latin America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 40: Latin America Market Share and BPS Analysis by Delivery, 2022 & 2027
Figure 41: Latin America Market Y-o-Y Growth Projections by Delivery, 2022 to 2027
Figure 42: Latin America Market Attractiveness Analysis by Delivery, 2022 to 2027
Figure 43: Latin America Market Share and BPS Analysis by Route of Administration, 2022 & 2027
Figure 44: Latin America Market Y-o-Y Growth Projections by Route of Administration, 2022 to 2027
Figure 45: Latin America Market Attractiveness Analysis by Route of Administration, 2022 to 2027
Figure 46: Latin America Market Share and BPS Analysis by Application, 2022 & 2027
Figure 47: Latin America Market Y-o-Y Growth Projections by Application, 2022 to 2027
Figure 48: Latin America Market Attractiveness Analysis by Application, 2022 to 2027
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 52: Europe Market Incremental $ Opportunity, 2022 to 2027
Figure 53: Europe Market Share Analysis by Country, 2022 & 2027
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 55: Europe Market Attractiveness Analysis by Country, 2022 to 2027
Figure 56: Europe Market Share and BPS Analysis by Delivery, 2022 & 2027
Figure 57: Europe Market Y-o-Y Growth Projections by Delivery, 2022 to 2027
Figure 58: Europe Market Attractiveness Analysis by Delivery, 2022 to 2027
Figure 59: Europe Market Share and BPS Analysis by Route of Administration, 2022 & 2027
Figure 60: Europe Market Y-o-Y Growth Projections by Route of Administration, 2022 to 2027
Figure 61: Europe Market Attractiveness Analysis by Route of Administration, 2022 to 2027
Figure 62: Europe Market Share and BPS Analysis by Application, 2022 & 2027
Figure 63: Europe Market Y-o-Y Growth Projections by Application, 2022 to 2027
Figure 64: Europe Market Attractiveness Analysis by Application, 2022 to 2027
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 68: East Asia Market Incremental $ Opportunity, 2022 to 2027
Figure 69: East Asia Market Share Analysis by Country, 2022 & 2027
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 71: East Asia Market Attractiveness Analysis by Country, 2022 to 2027
Figure 72: East Asia Market Share and BPS Analysis by Delivery, 2022 & 2027
Figure 73: East Asia Market Y-o-Y Growth Projections by Delivery, 2022 to 2027
Figure 74: East Asia Market Attractiveness Analysis by Delivery, 2022 to 2027
Figure 75: East Asia Market Share and BPS Analysis by Route of Administration, 2022 & 2027
Figure 76: East Asia Market Y-o-Y Growth Projections by Route of Administration, 2022 to 2027
Figure 77: East Asia Market Attractiveness Analysis by Route of Administration, 2022 to 2027
Figure 78: East Asia Market Share and BPS Analysis by Application, 2022 & 2027
Figure 79: East Asia Market Y-o-Y Growth Projections by Application, 2022 to 2027
Figure 80: East Asia Market Attractiveness Analysis by Application, 2022 to 2027
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2022 to 2027
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2022 & 2027
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2022 to 2027
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Delivery, 2022 & 2027
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Delivery, 2022 to 2027
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Delivery, 2022 to 2027
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Route of Administration, 2022 & 2027
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Route of Administration, 2022 to 2027
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Route of Administration, 2022 to 2027
Figure 94: South Asia & Oceania Market Share and BPS Analysis by Application, 2022 & 2027
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by Application, 2022 to 2027
Figure 96: South Asia & Oceania Market Attractiveness Analysis by Application, 2022 to 2027
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 100: MEA Market Incremental $ Opportunity, 2022 to 2027
Figure 101: MEA Market Share Analysis by Country, 2022 & 2027
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 103: MEA Market Attractiveness Analysis by Country, 2022 to 2027
Figure 104: MEA Market Share and BPS Analysis by Delivery, 2022 & 2027
Figure 105: MEA Market Y-o-Y Growth Projections by Delivery, 2022 to 2027
Figure 106: MEA Market Attractiveness Analysis by Delivery, 2022 to 2027
Figure 107: MEA Market Share and BPS Analysis by Route of Administration, 2022 & 2027
Figure 108: MEA Market Y-o-Y Growth Projections by Route of Administration, 2022 to 2027
Figure 109: MEA Market Attractiveness Analysis by Route of Administration, 2022 to 2027
Figure 110: MEA Market Share and BPS Analysis by Application, 2022 & 2027
Figure 111: MEA Market Y-o-Y Growth Projections by Application, 2022 to 2027
Figure 112: MEA Market Attractiveness Analysis by Application, 2022 to 2027
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the estimated value of the global gene delivery systems market?
The global market for gene delivery systems is estimated to reach US$ 4.1 billion by 2027.
How big is the gene delivery systems market?
The global gene delivery systems market is valued at US$ 3 billion.
What are the factors driving the growth of the gene delivery systems market?
Growing burden of chronic diseases & lifestyle disorders and technological advancements in research by biopharmaceutical companies are factors driving market growth.
What is the predicted growth rate of the gene delivery devices market?
The global gene delivery systems market is predicted to increase at 6.5% CAGR from 2022 to 2027.
Who are the key players in the gene delivery systems market?
Amgen, Inc., Bayer AG, and Pfizer, Inc. are key manufacturers of gene delivery systems.
Gene Delivery Systems Market